Skip to main content
. 2019 Sep 4;17(3):1559325819872583. doi: 10.1177/1559325819872583

Figure 5.

Figure 5.

In vitro DTX release from nanoparticles. At 37°C, the release of DTX from PPLNs or eTmab-PPLNs within 48 hours, respectively. Values are mean ± SD (n = 3). DTX indicates docetaxel; eTmab-PPLNs, electrostatically conjugated trastuzumab-bearing poly (d, l-lactide-co-glycolide)/polyethylenimine/lipid nanoparticles; PPLNs, poly (d, l-lactide-co-glycolide)/polyethylenimine/lipid nanoparticles.